{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:10:12Z","timestamp":1761718212348},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,3,30]],"date-time":"2012-03-30T00:00:00Z","timestamp":1333065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s13318-012-0089-6","type":"journal-article","created":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T05:40:05Z","timestamp":1332999605000},"page":"289-299","source":"Crossref","is-referenced-by-count":16,"title":["Bioavailability and in vivo efficacy of a praziquantel\u2013polyvinylpyrrolidone solid dispersion in Schistosoma mansoni-infected mice"],"prefix":"10.1007","volume":"37","author":[{"given":"Naglaa","family":"El-Lakkany","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayed Hassan","family":"Seif el-Din","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamia","family":"Heikal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,30]]},"reference":[{"key":"89_CR1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/03639049209043701","volume":"18","author":"M Akbarieh","year":"1992","unstructured":"Akbarieh M, Besner JG, Galal A, Tawashi R (1992) Liposomal system for the targeting and controlled release of praziquantel. Drug Dev Ind Pharm 18:303\u2013317","journal-title":"Drug Dev Ind Pharm"},{"key":"89_CR2","unstructured":"Andrews P (1976) Pharmacokinetic studies with Droncit in animals using a biological assay. Vet Med Rev 2:154\u2013165 (English Edition)"},{"key":"89_CR3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/00034983.1980.11687327","volume":"74","author":"P Andrews","year":"1980","unstructured":"Andrews P, Dycka J, Frank G (1980) Effect of praziquantel on clinical chemical parameters in healthy and schistosome-infected mice. Ann Trop Med Parasitol 74:167\u2013177","journal-title":"Ann Trop Med Parasitol"},{"key":"89_CR4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/030006059302100601","volume":"21","author":"AF Badawi","year":"1993","unstructured":"Badawi AF, Mostafa MH (1993) Possible mechanisms of alteration in the capacity of carcinogen-metabolizing enzymes during schistosomiasis. J Int Med Res 21:281\u2013305","journal-title":"J Int Med Res"},{"key":"89_CR5","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1645\/GE-865R.1","volume":"92","author":"SS Botros","year":"2006","unstructured":"Botros SS, Seif el-Din SH, El-Lakkany NM, Sabra AA, Ebeid FA (2006) Drug metabolizing enzymes and praziquantel bioavailability in mice harboring Schistosoma mansoni isolates of different drug susceptibilities. J Parasitol 92:1344\u20131349","journal-title":"J Parasitol"},{"key":"89_CR6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.exppara.2010.10.019","volume":"127","author":"S Botros","year":"2011","unstructured":"Botros S, El-Lakkany N, Seif el-Din SH, Sabra A, Ibrahim M (2011) Comparative efficacy and bioavailability of different praziquantel brands. Exp Parasitol 127:515\u2013521","journal-title":"Exp Parasitol"},{"key":"89_CR7","first-page":"254","volume":"21","author":"PC Brant","year":"1979","unstructured":"Brant PC, Prata A (1979) Altered drug metabolism in hepatosplenic schistosomiasis. Rev Inst Med Trop Sao Paulo 21:254\u2013259","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"89_CR8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cbpa.2007.05.031","volume":"11","author":"CR Caffrey","year":"2007","unstructured":"Caffrey CR (2007) Chemotherapy of schistosomiasis: present and future. Curr Opin Chem Biol 11:433\u2013439","journal-title":"Curr Opin Chem Biol"},{"key":"89_CR9","first-page":"328","volume":"39","author":"AW Cheever","year":"1968","unstructured":"Cheever AW (1968) Conditions affecting the accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues. Bull World Health Organ 39:328\u2013331","journal-title":"Bull World Health Organ"},{"key":"89_CR10","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/jps.2600581218","volume":"58","author":"WL Chiou","year":"1969","unstructured":"Chiou WL, Riegelman S (1969) Preparation and dissolution characteristics of several fast-release solid dispersions of griseofulvin. J Pharm Sci 58:1505\u20131510","journal-title":"J Pharm Sci"},{"key":"89_CR11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/jps.2600600902","volume":"60","author":"WL Chiou","year":"1971","unstructured":"Chiou WL, Riegelman S (1971) Pharmaceutical applications of solid dispersion systems. J Pharm Sci 60:1281\u20131302","journal-title":"J Pharm Sci"},{"key":"89_CR12","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ijpara.2004.05.001","volume":"34","author":"D Cioli","year":"2004","unstructured":"Cioli D, Botros S, Wheatcroft-Franklow K, Mbaye A, Southgate V, Tchuem-Tchuente L, Pica-Mattoccia L, Troiani AR, Seif el-Din S, Sabra A, Albin J, Engels D, Doenhoff M (2004) Determination of ED50 values for praziquantel in praziquantel-resistant and susceptible Schistosoma mansoni isolates. Int J Parasitol 34:979\u2013987","journal-title":"Int J Parasitol"},{"key":"89_CR13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.2042-7158.1984.tb04353.x","volume":"36","author":"OI Corrigan","year":"1984","unstructured":"Corrigan OI, Holohan EM (1984) Amorphous spray-dried hydroflumethiazide-polyvinylpyrrolidone systems: physiochemical properties. J Pharm Pharmacol 36:217\u2013221","journal-title":"J Pharm Pharmacol"},{"key":"89_CR14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.2042-7158.1975.tb09396.x","volume":"27","author":"OI Corrigan","year":"1975","unstructured":"Corrigan OI, Timoney RF (1975) The influence of polyvinylpyrrolidone on the dissolution properties of hydroflumethiazide. J Pharm Pharmacol 27:759\u2013764","journal-title":"J Pharm Pharmacol"},{"key":"89_CR15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0378-5173(01)00891-2","volume":"231","author":"DQM Craig","year":"2002","unstructured":"Craig DQM (2002) The mechanism of drug release from solid dispersion in water-soluble polymers. Int J Pharm 231:131\u2013144","journal-title":"Int J Pharm"},{"key":"89_CR16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/QCO.0b013e328318978f","volume":"21","author":"MJ Doenhoff","year":"2008","unstructured":"Doenhoff MJ, Cioli D, Utzinger J (2008) Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 21:659\u2013667","journal-title":"Curr Opin Infect Dis"},{"key":"89_CR17","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1017\/S0031182009000493","volume":"136","author":"MJ Doenhoff","year":"2009","unstructured":"Doenhoff MJ, Hagan P, Cioli D, Southgate V, Pica-Mattoccia L, Botros S, Coles G, Tchuem Tchuent\u00e9 LA, Mbaye A, Engels D (2009) Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs. Parasitology 136:1825\u20131835","journal-title":"Parasitology"},{"key":"89_CR18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4269\/ajtmh.1967.16.483","volume":"16","author":"RH Duvall","year":"1967","unstructured":"Duvall RH, De Witt WB (1967) Technique for recovering adult schistosomes from laboratory animals. Am J Trop Med Hyg 16:438\u2013486","journal-title":"Am J Trop Med Hyg"},{"key":"89_CR19","first-page":"867","volume":"50","author":"FA Ebeid","year":"2000","unstructured":"Ebeid FA, Seif el-Din SH, Ezzat AR (2000) Effect of Schistosoma mansoni infection and treatment on drug-metabolizing enzymes. Arzneimittelforschung 50:867\u2013874","journal-title":"Arzneimittelforschung"},{"key":"89_CR20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0031-6865(97)00051-4","volume":"73","author":"SK El-Arini","year":"1998","unstructured":"El-Arini SK, Leuenberger H (1998) Dissolution properties of praziquantel-PVP systems. Pharm Acta Helv 73:89\u201394","journal-title":"Pharm Acta Helv"},{"key":"89_CR21","doi-asserted-by":"crossref","first-page":"809","DOI":"10.4269\/ajtmh.1994.51.809","volume":"51","author":"MA El-Guiniady","year":"1994","unstructured":"El-Guiniady MA, El-Touny MA, Abdel-Bary MA, Abdel-Fatah SA, Metwally AA (1994) Clinical and pharmacokinetic study of praziquantel in Egyptian schistosomiasis patients with and without liver cell failure. Am J Trop Med Hyg 51:809\u2013818","journal-title":"Am J Trop Med Hyg"},{"key":"89_CR22","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ijpara.2004.08.012","volume":"34","author":"NM El-Lakkany","year":"2004","unstructured":"El-Lakkany NM, Seif el-Din SH, Badawy AA, Ebeid FA (2004) Effect of artemether alone and in combination with grapefruit juice on hepatic drug-metabolizing enzymes and biochemical aspects in experimental Schistosoma mansoni. Int J Parasitol 34:1405\u20131412","journal-title":"Int J Parasitol"},{"key":"89_CR23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.pt.2003.09.005","volume":"19","author":"A Fenwick","year":"2003","unstructured":"Fenwick A, Savioli L, Engels D, Robert Bergquist N, Todd MH (2003) Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol 19:509\u2013515","journal-title":"Trends Parasitol"},{"key":"89_CR24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0378-5173(01)00751-7","volume":"225","author":"M Franco","year":"2001","unstructured":"Franco M, Trapani G, Latrofa A, Tullio C, Provenzano MR, Serra M, Muggironi M, Biggio G, Liso G (2001) Dissolution properties and anticonvulsant activity of phenytoin-polyethylene glycol 6000 and -polyvinylpyrrolidone K-30 solid dispersions. Int J Pharm 225:63\u201373","journal-title":"Int J Pharm"},{"key":"89_CR25","doi-asserted-by":"crossref","DOI":"10.1201\/b14095","volume-title":"Pharmacokinetics","author":"M Gibaldi","year":"1982","unstructured":"Gibaldi M, Perrier D (1982) Pharmacokinetics, 2nd edn. Marcel Dekker Inc., New York","edition":"2"},{"key":"89_CR26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00389899","volume":"52","author":"R Gonnert","year":"1977","unstructured":"Gonnert R, Andrews P (1977) Praziquantel, a new broad-spectrum antischistosomal agent. Z Parasitenkd 52:129\u2013150","journal-title":"Z Parasitenkd"},{"key":"89_CR27","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s00436-003-0958-7","volume":"91","author":"ST Hong","year":"2003","unstructured":"Hong ST, Lee SH, Lee SJ, Kho WG, Lee M, Li S, Chung BS, Seo M, Choi MH (2003) Sustained-release praziquantel tablet: pharmacokinetics and the treatment of clonorchiasis in beagle dogs. Parasitol Res 91:316\u2013320","journal-title":"Parasitol Res"},{"key":"89_CR28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jps.2600740312","volume":"74","author":"KH Kim","year":"1985","unstructured":"Kim KH, Frank MJ, Henderson NL (1985) Application of differential scanning calorimetry to the study of solid drug dispersions. J Pharm Sci 74:283\u2013289","journal-title":"J Pharm Sci"},{"key":"89_CR29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00560463","volume":"14","author":"G Leopold","year":"1978","unstructured":"Leopold G, Ungethum W, Groll E, Diekmann HW, Nowak H, Wegner DH (1978) Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes. An example of a complex study covering both tolerance and pharmacokinetics. Eur J Clin Pharmacol 14:281\u2013291","journal-title":"Eur J Clin Pharmacol"},{"key":"89_CR30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00228-003-0636-9","volume":"59","author":"X-Q Li","year":"2003","unstructured":"Li X-Q, Bjorkman A, Andersson TB, Gustafsson LL, Masimirembwa CM (2003) Identification of human cytochrome P450s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data. Eur J Clin Pharmacol 59:429\u2013442","journal-title":"Eur J Clin Pharmacol"},{"key":"89_CR31","first-page":"34","volume":"1","author":"YS Liang","year":"1987","unstructured":"Liang YS, John BI, Boyd DA (1987) Laboratory cultivation of schistosome vector snails and maintenance of schistosome life cycles. Proceeding of the 1st Sino-American. Symposium 1:34\u201348","journal-title":"Symposium"},{"key":"89_CR32","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0020-7519(01)00246-6","volume":"31","author":"YS Liang","year":"2001","unstructured":"Liang YS, Coles GC, Doenhoff MJ, Southgate VR (2001) In vitro responses of praziquantel-resistant and -susceptible Schistosoma mansoni to praziquantel. Int J Parasitol 31:1227\u20131235","journal-title":"Int J Parasitol"},{"key":"89_CR33","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0020-7519(97)00052-0","volume":"27","author":"ML Lopez-Garcia","year":"1997","unstructured":"Lopez-Garcia ML, Torrado-Duran S, Torrado-Duran J, Mart\u00ednez-Fern\u00e1ndez AR, Bol\u00e1s-Fern\u00e1ndez F (1997) Albendazole versus ricobendazole (albendazole-sulphoxide) against enteral and parenteral stages of Trichinella spiralis in mice. Int J Parasitol 27:781\u2013785","journal-title":"Int J Parasitol"},{"key":"89_CR34","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0035-9203(90)90333-A","volume":"84","author":"ME Mandour","year":"1990","unstructured":"Mandour ME, El-Turabi H, Homeida MM, El-Sadig T, Ali HM, Bennett JL, Leahey WJ, Harron DW (1990) Pharmacokinetics of praziquantel in healthy volunteers and patients with schistosomiasis. Trans R Soc Trop Med Hyg 84:389\u2013393","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"89_CR35","first-page":"133","volume":"11","author":"AA Metwally","year":"1989","unstructured":"Metwally AA (1989) Pharmacokinetics of praziquantel in schistosomiasis patients. Egypt J Bilharz 11:133\u2013143","journal-title":"Egypt J Bilharz"},{"key":"89_CR36","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1371\/journal.pntd.0000357","volume":"3","author":"T Meyer","year":"2009","unstructured":"Meyer T, Sekljic H, Fuchs S, Bothe H, Schollmeyer D, Miculka C (2009) Taste, a new incentive to switch to (R)-Praziquantel in schistosomiasis treatment. PLoS Negl Trop Dis 3:e357","journal-title":"PLoS Negl Trop Dis"},{"key":"89_CR37","first-page":"625","volume":"52","author":"N Ozdemir","year":"1997","unstructured":"Ozdemir N, Ordu S (1997) Dissolution rate of furosemide from polyethylene glycol solid dispersions. Farmaco 52:625\u2013629","journal-title":"Farmaco"},{"key":"89_CR38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4269\/ajtmh.1962.11.201","volume":"11","author":"J Pellegrino","year":"1962","unstructured":"Pellegrino J, Oliveira CA, Faria J, Cunah AS (1962) New approach to the screening of drugs in experimental schistosomiasis mansoni in mice. Am J Trop Med Hyg 11:201\u2013215","journal-title":"Am J Trop Med Hyg"},{"key":"89_CR39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0378-5173(80)90091-5","volume":"6","author":"E Shefter","year":"1980","unstructured":"Shefter E, Cheng KC (1980) Drug-Polyvinylpyrrolidone (PVP) dispersions: a differential scanning colorimetric study. Int J Pharm 6:179\u2013182","journal-title":"Int J Pharm"},{"key":"89_CR40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0378-5173(94)90094-9","volume":"103","author":"MT Sheu","year":"1994","unstructured":"Sheu MT, Yeh CM, Sokoloski TD (1994) Characterization and dissolution of fenofibrate solid dispersion systems. Int J Pharm 103:137\u2013146","journal-title":"Int J Pharm"},{"key":"89_CR41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S0022149X00001012","volume":"72","author":"SA Sheweita","year":"1998","unstructured":"Sheweita SA, Mangoura SA, El-Shemi AG (1998) Different levels of Schistosoma mansoni infection induced changes in drug-metabolizing enzymes. J Helminthol 72:71\u201377","journal-title":"J Helminthol"},{"key":"89_CR42","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jps.2600580503","volume":"58","author":"AP Simonelli","year":"1969","unstructured":"Simonelli AP, Metha SC, Higuchi WI (1969) Dissolution rates of high-energy polyvinylpirrolidone-PVP-sulfathiazole coprecipitates. J Pharm Sci 58:538\u2013549","journal-title":"J Pharm Sci"},{"key":"89_CR43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jps.2600650310","volume":"65","author":"AP Simonelli","year":"1976","unstructured":"Simonelli AP, Mehta SC, Higuchi WI (1976) Dissolution rates of high-energy sulfathiazole-povidone coprecipitates. II: characterization of form of drug controlling its dissolution rate via solubility studies. J Pharm Sci 65:355\u2013361","journal-title":"J Pharm Sci"},{"key":"89_CR44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijpharm.2005.06.021","volume":"302","author":"H Susumu","year":"2005","unstructured":"Susumu H, Takeshi H, Naho F, Akira K, Etsuo Y, Katsuhide T (2005) Effects of water content in physical mixture and heating temperature on crystallinity of troglitazone-PVP K30 solid dispersions prepared by closed melting method. Int J Pharm 302:103\u2013112","journal-title":"Int J Pharm"},{"key":"89_CR45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0378-5173(96)04687-X","volume":"143","author":"V Tantishaiyakul","year":"1996","unstructured":"Tantishaiyakul V, Kaewnopparat N, Ingkatawornwong S (1996) Properties of solid dispersions of piroxicam in polyvinylpyrrolidone K-30. Int J Pharm 143:59\u201366","journal-title":"Int J Pharm"},{"key":"89_CR46","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1023\/A:1012167410376","volume":"14","author":"LS Taylor","year":"1997","unstructured":"Taylor LS, Zografi G (1997) Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res 14:1691\u20131698","journal-title":"Pharm Res"},{"key":"89_CR47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0169-4758(88)90047-6","volume":"4","author":"BL Tekwanl","year":"1988","unstructured":"Tekwanl BL, Shukla OP, Ghatak S (1988) Altered drug metabolism in parasitic diseases. Parasitol Today 4:4\u201310","journal-title":"Parasitol Today"},{"key":"89_CR48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0378-5173(96)04586-3","volume":"140","author":"S Torrado","year":"1996","unstructured":"Torrado S, Torrado S, Torrado JJ, Cadorniga R (1996) Preparation, dissolution and characterization of albendazole solid dispersions. Int J Pharm 140:247\u2013250","journal-title":"Int J Pharm"},{"key":"89_CR49","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1248\/cpb.47.1629","volume":"47","author":"P Torre","year":"1999","unstructured":"Torre P, Torrado S, Torrado S (1999) Preparation, dissolution and characterization of praziquantel solid dispersions. Chem Pharm Bull 47:1629\u20131633","journal-title":"Chem Pharm Bull"},{"key":"89_CR50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0378-5173(97)00401-8","volume":"164","author":"G Mooter Van den","year":"1998","unstructured":"Van den Mooter G, Augustijns P, Blaton N, Kinget R (1998) Physicochemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int J Pharm 164:67\u201380","journal-title":"Int J Pharm"},{"key":"89_CR51","unstructured":"WHO (2008) Model lists of essential medicines. Available via the Internet http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en\/ . Accessed 1 Sept 2008"},{"key":"89_CR52","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ijpara.2004.04.005","volume":"34","author":"S William","year":"2004","unstructured":"William S, Botros S (2004) Validation of sensitivity to praziquantel using Schistosoma mansoni worm muscle tension and Ca2+-uptake as possible in vitro correlates to in vivo ED50 determination. Int J Parasitol 34:971\u2013977","journal-title":"Int J Parasitol"},{"key":"89_CR53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S0031182000007137","volume":"122","author":"S William","year":"2001","unstructured":"William S, Botros S, Ismail M, Farghally A, Day TA, Bennett JL (2001a) Praziquantel-induced tegumental damage in vitro is diminished in schistosomes derived from praziquantel-resistant infections. Parasitology 122:63\u201366","journal-title":"Parasitology"},{"key":"89_CR54","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0020-7519(01)00215-6","volume":"31","author":"S William","year":"2001","unstructured":"William S, Sabra A, Ramzy F, Mousa M, Demerdash Z, Bennett J, Day TA, Botros S (2001b) Stability and reproductive fitness of Schistosoma mansoni isolates with decreased sensitivity to praziquantel. Int J Parasitol 31:1093\u20131100","journal-title":"Int J Parasitol"},{"key":"89_CR55","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0378-4347(00)84351-0","volume":"275","author":"SH Xiao","year":"1983","unstructured":"Xiao SH, Catto BA, Webster LT (1983) Quantitative determination of praziquantel in serum by high performance liquid chromatography. J Chromatogr 275:127\u2013132","journal-title":"J Chromatogr"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-012-0089-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13318-012-0089-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-012-0089-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T15:54:02Z","timestamp":1641657242000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13318-012-0089-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,30]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["89"],"URL":"https:\/\/doi.org\/10.1007\/s13318-012-0089-6","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,30]]}}}